Skip to content
value.today

Endochoice, Inc.

🇺🇸 Alpharetta, Georgia, USAHealth CareFounded 2007

Formerly ENDOCHOICE INC

Total raised
$15 M
3 rounds on record
Latest round
$4 M
Dec 2010
First round on record
Aug 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Endochoice, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2010$4 MNo. 3$2 to $10 million

Endochoice, Inc.: Raise no. 3, Dec 2010

Investors in this round

11 investors had bought by the notice of Jan 12, 2011: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $0 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gregg Edward Costantino · Executive Officer · Vice President of Sales
  • James B. Young, Jr. · Executive Officer · General Counsel and Corporate Secretary
  • Louis Malice · Executive Officer · Chief Operating Officer
  • Mark Gilreath · Executive Officer, Director · Chief Executive Officer
  • Scott Edward Fraser · Executive Officer · Vice President of Marketing
  • T. Edward Mitchell · Executive Officer · Vice President of Finance and Administration
  • William Edward Parks · Executive Officer · Vice President of Business Development
  • Blair B. Lewis · Director
  • David R Kaufman · Director
  • Grant B. Jackson · Director
  • James R Balkcom · Director
  • Joel B. Brill · Director
  • Rik B. Vandevenne · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James B. Young, Jr., General counsel & secretary. Source: SEC Form D, newest notice filed Jan 12, 2011. Read the notice at the SEC.

equitySEC
Jun 2010$8 MNo. 2$2 to $10 million

Endochoice, Inc.: Raise no. 2, Jun 2010

Investors in this round

10 investors had bought by the notice of Jun 29, 2010: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered; $0 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gregg Edward Costantino · Executive Officer · Vice President of Sales
  • James B. Young, Jr. · Executive Officer · General Counsel and Corporate Secretary
  • Louis Malice · Executive Officer · Chief Operating Officer
  • Mark Gilreath · Executive Officer, Director · Chief Executive Officer
  • Scott Edward Fraser · Executive Officer · Vice President of Marketing
  • T. Edward Mitchell · Executive Officer · Vice President of Finance and Administration
  • William Edward Parks · Executive Officer · Vice President of Business Development
  • Blair B. Lewis · Director
  • David R Kaufman · Director
  • Grant B. Jackson · Director
  • James R Balkcom · Director
  • Joel B. Brill · Director
  • Rik B. Vandevenne · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James B. Young, Jr., General counsel & secretary. Source: SEC Form D, newest notice filed Jun 29, 2010. Read the notice at the SEC.

equitySEC
Aug 2009$3 MNo. 1$2 to $10 million

Endochoice, Inc.: Raise no. 1, Aug 2009

Investors in this round

3 investors had bought by the notice of Sep 1, 2009: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $8 M offered; $4 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gregg Costantino · Executive Officer · Vice President of Sales
  • James B. Young, Jr. · Executive Officer · General Counsel and Corporate Secretary
  • Louis Malice · Executive Officer · Chief Operating Officer
  • Mark Gilreath · Executive Officer, Director · Chief Executive Officer
  • Scott Fraser · Executive Officer · Vice President of Marketing
  • T. Edward Mitchell · Executive Officer · Vice President of Finance and Administration
  • William Parks · Executive Officer · Vice President of Business Development
  • Blair Lewis · Director
  • Ed Mccarthy · Director
  • Grant Jackson · Director
  • James Balkcom · Director
  • Joel Brill · Director
  • Rik Vandevenne · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James B. Young, Jr., General counsel & secretary. Source: SEC Form D, newest notice filed Sep 1, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Endochoice, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2011).

    SEC Form D · Jan 2011

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2011

That is all the official record says: Endochoice, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Endochoice, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Endochoice, Inc.
NameRoleNamed in
Gregg Edward CostantinoVice President of SalesJan 2011
James B. Young, Jr.General Counsel and Corporate SecretaryJan 2011
Louis MaliceChief Operating OfficerJan 2011
Mark GilreathChief Executive OfficerJan 2011
Scott Edward FraserVice President of MarketingJan 2011
T. Edward MitchellVice President of Finance and AdministrationJan 2011
William Edward ParksVice President of Business DevelopmentJan 2011
Gregg CostantinoVice President of SalesSep 2009
Scott FraserVice President of MarketingSep 2009
William ParksVice President of Business DevelopmentSep 2009
Blair B. LewisDirectorJan 2011
David R KaufmanDirectorJan 2011
Grant B. JacksonDirectorJan 2011
James R BalkcomDirectorJan 2011
Joel B. BrillDirectorJan 2011
Mark GilreathChief Executive OfficerJan 2011
Rik B. VandevenneDirectorJan 2011
Blair LewisDirectorSep 2009
Ed MccarthyDirectorSep 2009
Grant JacksonDirectorSep 2009
James BalkcomDirectorSep 2009
Joel BrillDirectorSep 2009
Rik VandevenneDirectorSep 2009